Response to Letter to the Editor: "Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care"

Matthew Genco¹, Lisa Anderson-Shaw², Robert M Sargis^{1

3}

Affiliations

¹ Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
² Department of Medical Education, University of Illinois at Chicago, Chicago, Illinois.
³ Chicago Center for Health and Environment (CACHET); University of Illinois at Chicago, Chicago, Illinois.

Comment

Matthew Genco et al. J Clin Endocrinol Metab. 2021.

. 2021 Jan 23;106(2):e1066-e1067.

doi: 10.1210/clinem/dgaa714.

Matthew Genco¹, Lisa Anderson-Shaw², Robert M Sargis^{1

3}

¹ Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
² Department of Medical Education, University of Illinois at Chicago, Chicago, Illinois.
³ Chicago Center for Health and Environment (CACHET); University of Illinois at Chicago, Chicago, Illinois.

No abstract available

Comment on

Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care.
Genco M, Anderson-Shaw L, Sargis RM. Genco M, et al. J Clin Endocrinol Metab. 2020 Oct 1;105(10):e3822-7. doi: 10.1210/clinem/dgaa358. J Clin Endocrinol Metab. 2020. PMID: 32614432 Free PMC article.
Letter to the Editor from Napierska and Schettler: "Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care".
Napierska D, Schettler T. Napierska D, et al. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e1062-e1063. doi: 10.1210/clinem/dgaa713. J Clin Endocrinol Metab. 2021. PMID: 33029636 No abstract available.

1. Napierska D, Schettler T. Letter to the editor from Dorata Napierska et al.: unwitting accomplices: endocrine disruptors confounding clinical care. J Clin Endocrinol Metab. 2020;105(10):dgaa358. - PubMed
1. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745. Accessed September 20, 2020.
1. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER). Guidance for Industry: Limiting the Use of Certain Phthalates as Excipients in CDER Regulated Products. Washington, DC: United States Department of Health and Human Services; 2012.
1. Health Care Without Harm. Leading the global movement for environmentally responsible health care. Reston, VA. https://noharm.org. Accessed September 20, 2020.